Receptors, Transforming Growth Factor beta
"Receptors, Transforming Growth Factor beta" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell-surface proteins that bind transforming growth factor beta and trigger changes influencing the behavior of cells. Two types of transforming growth factor receptors have been recognized. They differ in affinity for different members of the transforming growth factor beta family and in cellular mechanisms of action.
Descriptor ID |
D018125
|
MeSH Number(s) |
D12.776.543.750.705.852.720 D12.776.543.750.750.400.820
|
Concept/Terms |
Receptors, Transforming Growth Factor beta- Receptors, Transforming Growth Factor beta
- Transforming Growth Factor beta Receptors
- Receptors, TGF-beta
- Receptors, TGF beta
- TGF-beta Receptor
- Receptor, TGF-beta
- TGF beta Receptor
- TGF-beta Receptors
- TGF beta Receptors
- Transforming Growth Factor beta Receptor
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Transforming Growth Factor beta".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Transforming Growth Factor beta".
This graph shows the total number of publications written about "Receptors, Transforming Growth Factor beta" by people in UAMS Profiles by year, and whether "Receptors, Transforming Growth Factor beta" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2021 | 0 | 2 | 2 | 2018 | 0 | 1 | 1 | 2017 | 0 | 1 | 1 | 2015 | 1 | 1 | 2 | 2014 | 1 | 0 | 1 | 2013 | 0 | 2 | 2 | 2010 | 2 | 0 | 2 | 2008 | 1 | 1 | 2 | 2004 | 0 | 2 | 2 | 2001 | 1 | 0 | 1 | 2000 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Transforming Growth Factor beta" by people in Profiles over the past ten years.
-
Kharbanda A, Zhang L, Saha D, Tran P, Xu K, Li MO, Leung YK, Frett B, Li HY. Discovery and biological evaluation of phthalazines as novel non-kinase TGFß pathway inhibitors. Eur J Med Chem. 2021 Nov 05; 223:113660.
-
Caza TN, Hassen SI, Kenan DJ, Storey A, Arthur JM, Herzog C, Edmondson RD, Bourne TD, Beck LH, Larsen CP. Transforming Growth Factor Beta Receptor 3 (TGFBR3)-Associated Membranous Nephropathy. Kidney360. 2021 08 26; 2(8):1275-1286.
-
Jiang L, Han X, Wang J, Wang C, Sun X, Xie J, Wu G, Phan H, Liu Z, Yeh ETH, Zhang C, Zhao M, Kang X. SHP-1 regulates hematopoietic stem cell quiescence by coordinating TGF-ß signaling. J Exp Med. 2018 05 07; 215(5):1337-1347.
-
Jin HY, Oda H, Chen P, Yang C, Zhou X, Kang SG, Valentine E, Kefauver JM, Liao L, Zhang Y, Gonzalez-Martin A, Shepherd J, Morgan GJ, Mondala TS, Head SR, Kim PH, Xiao N, Fu G, Liu WH, Han J, Williamson JR, Xiao C. Differential Sensitivity of Target Genes to Translational Repression by miR-17~92. PLoS Genet. 2017 02; 13(2):e1006623.
-
Trikha S, Saffari E, Nongpiur M, Baskaran M, Ho H, Li Z, Tan PY, Allen J, Khor CC, Perera SA, Cheng CY, Aung T, Vithana E. A Genetic Variant in TGFBR3-CDC7 Is Associated with Visual Field Progression in Primary Open-Angle Glaucoma Patients from Singapore. Ophthalmology. 2015 Dec; 122(12):2416-22.
-
Pépin D, Sosulski A, Zhang L, Wang D, Vathipadiekal V, Hendren K, Coletti CM, Yu A, Castro CM, Birrer MJ, Gao G, Donahoe PK. AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancer. Proc Natl Acad Sci U S A. 2015 Aug 11; 112(32):E4418-27.
-
Nadauld LD, Garcia S, Natsoulis G, Bell JM, Miotke L, Hopmans ES, Xu H, Pai RK, Palm C, Regan JF, Chen H, Flaherty P, Ootani A, Zhang NR, Ford JM, Kuo CJ, Ji HP. Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer. Genome Biol. 2014 Aug 27; 15(8):428.
-
Yeung TL, Leung CS, Wong KK, Samimi G, Thompson MS, Liu J, Zaid TM, Ghosh S, Birrer MJ, Mok SC. TGF-ß modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment. Cancer Res. 2013 Aug 15; 73(16):5016-28.
-
Zhen G, Wen C, Jia X, Li Y, Crane JL, Mears SC, Askin FB, Frassica FJ, Chang W, Yao J, Carrino JA, Cosgarea A, Artemov D, Chen Q, Zhao Z, Zhou X, Riley L, Sponseller P, Wan M, Lu WW, Cao X. Inhibition of TGF-ß signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med. 2013 Jun; 19(6):704-12.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|